Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side-effect of bisphosphonate therapy. In the majority of cases BRONJ occurs in the mandible. As a consequence a detailed investigation of BRONJ of the maxilla and in particular of involvement of the maxillary sinus has largely so far been neglected. The aim of this study was to analyse the frequency of maxillary sinusitis and oro-antral fistulae in BRONJ of the maxilla.
A retrospective multicentre analysis was carried out in three Departments of Oral and Maxillofacial Surgery focussing on patients suffering from BRONJ in the maxilla. The role of involvement of the maxillary sinus, in particular sinusitis and oro-antral fistula, was analysed.
Out of a total of 170 patients suffering from BRONJ 53 cases (31.2%) with involvement of the maxilla were identified. At least one sign of maxillary sinusitis was present in 43.6% (23/53) and an oro-antral fistula in the course of the disease was detected in 35.8% (19/53) of those patients. The mean length of time of bisphosphonate intake was 36.16±16.32 months. Zoledronate was most frequently associated (60.4%) with symptoms, followed by the combination of Zoledronate/Ibandronate (13.2%), and Zoledronate/Pamidronate or Pamidronate alone (both 7.5%).
Maxillary sinusitis and oro-antral fistulae are associated with a BRONJ manifestation in the upper jaw in approximately 44%. The involvement of the maxillary sinus should be given special attention and three-dimensional imaging modalities might be necessary, not only to evaluate the extent of necrosis, but also to exclude involvement of the maxillary sinus.
AuthorsGerson Mast, Sven Otto, Thomas Mücke, Christian Schreyer, Oliver Bissinger, Andreas Kolk, Klaus Dietrich Wolff, Michael Ehrenfeld, Stephen R Stürzenbaum, Christoph Pautke
JournalJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery (J Craniomaxillofac Surg) Vol. 40 Issue 7 Pg. 568-71 (Oct 2012) ISSN: 1878-4119 [Electronic] Scotland
PMID22118926 (Publication Type: Journal Article, Multicenter Study)
CopyrightCopyright © 2011 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • ibandronic acid
  • zoledronic acid
  • pamidronate
  • Bisphosphonate-Associated Osteonecrosis of the Jaw (complications)
  • Bone Density Conservation Agents (administration & dosage, adverse effects)
  • Cone-Beam Computed Tomography
  • Diphosphonates (administration & dosage, adverse effects)
  • Female
  • Humans
  • Imidazoles (administration & dosage, adverse effects)
  • Male
  • Maxillary Diseases (complications)
  • Maxillary Sinusitis (etiology)
  • Oroantral Fistula (etiology)
  • Radiography, Panoramic
  • Retrospective Studies
  • Time Factors
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: